Alexander K. So

Startlab, Alanine Building, Route De La Corniche 5
Epalinges, VD 1066, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Allosteric activators of cystathionine γ lyase to augment endogenous hydrogen sulfide and inhibit pathologic calcification.

Allosteric activators of cystathionine γ lyase to augment endogenous hydrogen sulfide and inhibit pathologic calcification.

Journal: Pharmacological research

Published: June 03, 2025

Advances in treatment of hyperuricemia and gout.

Advances in treatment of hyperuricemia and gout.

Journal: Therapeutische Umschau. Revue therapeutique

Published: November 07, 2024

Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort.

Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 21, 2024

The integrin CD11b inhibits MSU-induced NLRP3 inflammasome activation in macrophages and protects mice against MSU-induced joint inflammation.

The integrin CD11b inhibits MSU-induced NLRP3 inflammasome activation in macrophages and protects mice against MSU-induced joint inflammation.

Journal: Arthritis research & therapy

Published: February 05, 2024

Inhibiting Lysyl Oxidases prevents pathologic cartilage calcification.

Inhibiting Lysyl Oxidases prevents pathologic cartilage calcification.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 13, 2023

The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease.

The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease.

Journal: Annals of the rheumatic diseases

Published: June 14, 2023

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease.

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 08, 2023

Cartilage calcification in osteoarthritis: mechanisms and clinical relevance.

Cartilage calcification in osteoarthritis: mechanisms and clinical relevance.

Journal: Nature reviews. Rheumatology

Published: November 07, 2022

Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout.

Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 13, 2022

Management of hyperuricemia in chronic kidney disease

Management of hyperuricemia in chronic kidney disease

Journal: Revue medicale suisse

Published: March 02, 2022

Fibrin deposition associates with cartilage degeneration in arthritis.

Fibrin deposition associates with cartilage degeneration in arthritis.

Journal: EBioMedicine

Published: January 21, 2022

The Gasotransmitter Hydrogen Sulfide (H2S) Prevents Pathologic Calcification (PC) in Cartilage.

The Gasotransmitter Hydrogen Sulfide (H2S) Prevents Pathologic Calcification (PC) in Cartilage.

Journal: Antioxidants (Basel, Switzerland)

Published: August 06, 2021

Showing 1-12 of 95

Last Updated: 09/26/2026